Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia

PLoS One. 2021 Sep 9;16(9):e0256531. doi: 10.1371/journal.pone.0256531. eCollection 2021.

Abstract

Introduction: Active-case finding (ACF) programs have an important role in addressing case detection gaps and halting tuberculosis (TB) transmission. Evidence is limited on the cost-effectiveness of ACF interventions, particularly on how their value is impacted by different operational, epidemiological and patient care-seeking patterns.

Methods: We evaluated the costs and cost-effectiveness of a combined facility and community-based ACF intervention in Zambia that utilized mobile chest X-ray with computer-aided reading/interpretation software and laboratory-based Xpert MTB/RIF testing. Programmatic costs (in 2018 US dollars) were assessed from the health system perspective using prospectively collected cost and operational data. Cost-effectiveness of the ACF intervention was assessed as the incremental cost per TB death averted over a five-year time horizon using a multi-stage Markov state-transition model reflecting patient symptom-associated care-seeking and TB care under ACF compared to passive care.

Results: Over 18 months of field operations, the ACF intervention costed $435 to diagnose and initiate treatment for one person with TB. After accounting for patient symptom-associated care-seeking patterns in Zambia, we estimate that this one-time ACF intervention would incrementally diagnose 407 (7,207 versus 6,800) TB patients and avert 502 (611 versus 1,113) TB-associated deaths compared to the status quo (passive case finding), at an incremental cost of $2,284 per death averted over the next five-year period. HIV/TB mortality rate, patient symptom-associated care-seeking probabilities in the absence of ACF, and the costs of ACF patient screening were key drivers of cost-effectiveness.

Conclusions: A one-time comprehensive ACF intervention simultaneously operating in public health clinics and corresponding catchment communities can have important medium-term impact on case-finding and be cost-effective in Zambia. The value of such interventions increases if targeted to populations with high HIV/TB mortality, substantial barriers (both behavioral and physical) to care-seeking exist, and when ACF interventions can optimize screening by achieving operational efficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cost-Benefit Analysis*
  • Humans
  • Mass Screening / economics*
  • Tuberculosis / diagnosis
  • Tuberculosis / economics*
  • Tuberculosis / epidemiology*
  • Tuberculosis / transmission
  • Zambia / epidemiology

Grants and funding

This study was funded by the Stop TB Partnership at the UNOPS through the TB REACH wave 5 grant. TB REACH – an initiative of Stop TB Partnership – is funded by Global Affairs Canada [grant number CA-3-D000920001] and The Bill and Melinda Gates Foundation [OPP1139029]. This study was also funded by the Korea Health Technology Research and Development Project through support from the Korea Health Industry Development Institute and the Ministry of Health and Welfare, Republic of Korea, in the form of funds to HS [H19C1235]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.